I
keep hoping for some innovative brain tumor cure, something unintuitive, daring
and effective.
Here’s
a long, interesting, tantalizing article from the Emily Eakin in the New Yorker magazine about one such potential
solution from a brilliant surgeon, Dr. Paul Muizelaar who has treated
glioblastoma with “…Enterobacter aerogenes, a common fecal bacterium.”
For me that fulfilled two of the three criterion: unintuitive and daring. The third, "effective", is still TBD.
For me that fulfilled two of the three criterion: unintuitive and daring. The third, "effective", is still TBD.
Eakin
writes that “The surgeons had no data to suggest what might constitute a
therapeutic dose of Enterobacter, or a safe delivery method. The procedure was
heretical in principle: deliberately exposing a patient to bacteria in the
operating room violated a basic tenet of modern surgery, the concept known as
“maintaining a sterile field,” which, along with prophylactic antibiotics, is
credited with sharply reducing complications and mortality rates.”
So
guess what happened?
“For four weeks, Egan lay in intensive care, most of the
time in a coma. Then, on the afternoon of November 10th, Muizelaar learned that
a scan of Egan’s brain had failed to pick up the distinctive signature of
glioblastoma. The pattern on the scan suggested that the tumor had been
replaced by an abscess—an infection—precisely as the surgeons had intended. ‘A
brain abscess can be treated, a glioblastoma cannot,’ Muizelaar told me. ‘I was
excited, although I knew that clinically the patient was not better.’”